We report the recurrence rate and survival time in 31 patients with carcinoma of the breast who were treated by limited excision of the primary tumour and no other therapy. At three years the overall recurrence rate in the breast was 28%. One patient was found to have systemic disease and two died ofother causes. The overall recurrence rate in the breast at five years was 33%. One patient died of disseminated disease at 6 years 4 months.
Introduction
During a review of cases presenting between 1968 and 1974 with operable breast cancer Tl-T2 NO treated by local excision and high voltage X-ray therapy (HVT), a small group of patients was found in whom, for a variety of reasons, a wide 'biopsy excision' had been the only treatment. All have been carefully followed up and reviewed during the last six months.
There were 31 patients in the series. Prior to treatment each patient had been screened for metastatic disease by full clinical examination, radiography or radioisotope scanning. In no case was there evidence of disseminated disease at the time of diagnosis.
Results
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45 50 55 60 65 70 75 80+ Age (years) TNM classification: All patients had small primary tumours (TI or T2) and were considered to have uninvolved axillary lymph nodes (NO) on clinical examination.
Pathology: All specimens were reviewed in the Histopathology Department of the Royal Marsden Hospital and are classified as shown in Tables I and 2 . Though the series is small, there is nothing remarkable in the distribution of the pathological types. Three-year review: Twenty-eight patients were treated three or more years before review. Of these, one patient was lost to follow up and two had died of other causes, aged 104 and 76. Twenty-five patients were alive and were reviewed. Seven (28Ic,) ofthese had had a recurrence in the breast or axilla, but had no other evidence of metastatic disease (Table 3) . One patient had developed osseous deposits and remained alive under treatment at three years.
Five-year review: Sixteen patients were treated five or more years before review. One patient was lost to follow up and fifteen remained alive and were reviewed. Ofthese, 5 patients (33%) had had a local recurrence in the breast or axilla, without evidence of dissemination (Table 4) , and one patient had developed osseous metastases.
Since that time, one patient, successfully treated for local disease at five years, has been found to have disseminated disease 84 months after primary treatment by local excision, and is currently being treated.
Patients with disseminated disease: Two patients were found to have systemic disease during the period of follow up: (I) lV, aged 42, developed osseous deposits at 32 months. She was treated with hormonal ablation, chemotherapy and radiotherapy, and died 76 months after primary 
Discussion
Treatment of breast cancer by radical surgery with or without radiotherapy has as its objective cure of the patient, or at least the prevention of distressing local recurrence. It is widely believed that recurrence in the operation area predisposes to early dissemination and, since we now realize that the curative role of mastectomy is at least debatable, treatment is directed to preventing local tumour recurrence. In this series excision of a mammary carcinoma has been followed by a lower rate of local recurrence and a longer interval before recurrence than is popularly believed.
Stage I cases treated by tylectomy and HVT in the Guy's Hospital trial (Atkins et al. 1972 )had local recurrence rates of 15% at three years and 20% at five years. Mastectomy alone in the King's College Hospital series (Cancer Research Campaign 1976)gave local recurrence rates of 16%at three years and 26<j;, at fiveyears. These are lower than the local recurrence rates (28~~and 33~~) in the present series.
There has been distant recurrence within five years in only one patient in our series, giving rates of4% at three years and 7% at fiveyears. Radical surgery and HVT for Stage I disease in the Guy's Hospital trial (Atkins et al. 1972 )did not prevent distant recurrence in 22% at three years and 26~~at five years.
Overall survival rates at three and at five years are higher in our study than in the other series. In the Guy's Hospital trial (Atkins et al. 1972 ) 15% of patients treated by tylectomy and HVT were dead at three years and 20% at five years; in the King's College Hospital series (Cancer Research Campaign 1976) 13% were dead at three years after mastectomy with or without radiotherapy, and 22% were dead at five years; in our study no patient had died from breast cancer at three years or at five years. Of the 28 patients followed for three years, 2 (7%) died of other causes.
In none of these series were staging axillary dissections carried out, so there may have been a number of node-positive cases in all of them, perhaps 18/ 0 (Schottenfeld et al. 1976 , van Dongen 1977 .
Conclusion
This clinical study has not been reported in order to advocate minimal therapy or to adopt a nihilistic attitude to the problem of breast cancer. What it suggests is that the surgical removal of a carcinoma ofthe breast is not necessarily followed by early local recurrence and dissemination, and that a significant number of patients will survive for more than five years. The only definite conclusion that can be reached from these findings is that enlarging the scope of radical surgery and radiotherapy may have little influence on the overall survival time. This fact should be considered carefully when planning treatment.
